Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,981,539
  • Shares Outstanding, K 308,651
  • Annual Sales, $ 2,394 M
  • Annual Income, $ -83,990 K
  • 60-Month Beta 1.23
  • Price/Sales 0.82
  • Price/Cash Flow 4.70
  • Price/Book N/A
Trade AMRX with:

Options Overview Details

View History
  • Implied Volatility 36.50% ( -103.66%)
  • Historical Volatility 26.27%
  • IV Percentile 3%
  • IV Rank 6.81%
  • IV High 219.15% on 11/07/23
  • IV Low 23.16% on 06/05/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 133
  • Volume Avg (30-Day) 349
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 3,420
  • Open Int (30-Day) 7,481

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.11
  • Number of Estimates 2
  • High Estimate 0.12
  • Low Estimate 0.09
  • Prior Year 0.16
  • Growth Rate Est. (year over year) -31.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.29 +3.97%
on 06/28/24
7.25 -9.79%
on 06/12/24
-0.14 (-2.10%)
since 05/31/24
3-Month
5.18 +26.25%
on 04/22/24
7.25 -9.79%
on 06/12/24
+0.73 (+12.56%)
since 04/02/24
52-Week
2.29 +185.59%
on 07/05/23
7.25 -9.79%
on 06/12/24
+3.44 (+110.97%)
since 06/30/23

Most Recent Stories

More News
Amneal: Q1 Earnings Snapshot

Amneal: Q1 Earnings Snapshot

AMRX : 6.54 (+1.87%)
Amneal: Q4 Earnings Snapshot

Amneal: Q4 Earnings Snapshot

AMRX : 6.54 (+1.87%)
Amneal: Q3 Earnings Snapshot

Amneal: Q3 Earnings Snapshot

AMRX : 6.54 (+1.87%)
Amneal: Q2 Earnings Snapshot

Amneal: Q2 Earnings Snapshot

AMRX : 6.54 (+1.87%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amneal Pharmaceuticals, Inc. - AMRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NYSE: AMRX). Such...

AMRX : 6.54 (+1.87%)
MP Materials, Wolfspeed rise; Amneal, Knight-Swift fall, Wednesday, 7/5/2023

Stocks that traded heavily or had substantial price changes on Wednesday: MP Materials, Wolfspeed rise; Amneal, Knight-Swift fall

BRGYY : 15.2200 (unch)
AMRX : 6.54 (+1.87%)
INCY : 59.02 (-3.04%)
BG : 110.38 (+2.85%)
VRTX : 473.78 (+0.54%)
CVX : 156.75 (+0.15%)
UPS : 134.91 (-0.76%)
Why Shares of Amneal Pharmaceuticals Are Plunging Wednesday

The company received a complete response letter from the FDA regarding a Parkinson's disease generic therapy.

AMRX : 6.54 (+1.87%)
Amneal: Q1 Earnings Snapshot

Amneal: Q1 Earnings Snapshot

AMRX : 6.54 (+1.87%)
Amneal Reports First Quarter 2023 Financial Results

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) announced its actual results today for the first quarter ended March 31, 2023.

AMRX : 6.54 (+1.87%)
Amneal to Participate at the 22nd Annual Needham Virtual Healthcare Conference

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate...

AMRX : 6.54 (+1.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 6.87
2nd Resistance Point 6.71
1st Resistance Point 6.63
Last Price 6.54
1st Support Level 6.39
2nd Support Level 6.23
3rd Support Level 6.15

See More

52-Week High 7.25
Last Price 6.54
Fibonacci 61.8% 5.36
Fibonacci 50% 4.77
Fibonacci 38.2% 4.18
52-Week Low 2.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar